Trial intelligence / Profile preview

BICARb

NCT05918029Phase 3Terminated

Sponsor
Albert Einstein College of Medicine
Start
Aug 2024
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of potassium citrate in osteoporosis, sponsored by Albert Einstein College of Medicine. Started Aug 2024; status: terminated.

02

Drugs

potassium citrate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT05918029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05918029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call